Key Biologics, LLC

Specialties

Key Biologic’s goal and our clients goals are the same: To advance life science from discovery, through R&D and into curing disease. The organization provides unique and high-​value human-​derived biomaterials (cells and blood components), derived from human blood, umbilical cord, and bone marrow. In that effort Key Biologics supports the work of research worldwide, at major universities, and in early-​stage biotech companies and large drug companies.

History

Established in 2009.

Key Biologics, LLC (KEY) is a private, for-​profit company. It was incorporated in February 2009 and began operations on May 1, 2009 after acquiring the assets of Lifeblood Biological Services, which was a wholly-​owned subsidiary of the Mid-​South Regional Blood Center (Lifeblood). KEY collects biological products from screened, qualified, and compensated human donors and provides the products to customers across the United States and overseas. Products provided are primarily used to support pre-​clinical research, process development or validation, or production of in vitro diagnostics, but some are further manufactured for use in clinical trials.

Meet the Business Owner

Edward S.

Business Owner

Dr. Scott is a physician, board certified in Internal Medicine, Hematology and Transfusion Medicine (Blood Banking). He served as the Medical Director and CEO of the Mid-​South Regional Blood Center (Lifeblood) from 1986 until 2008. In that position, he created Lifeblood Biological Services (LBS) as a subsidiary of Lifeblood to focus on providing blood components and associated services to the biotech community and especially to the emerging cellular therapy industry. In 2009, he purchased LBS and created Key Biologics to continue the business as a for-​profit business.